Login / Signup
Chronic myeloid leukaemia and the use of tyrosine kinase inhibitors in the days of COVID-19 pandemic.
Ahmet Emre Eskazan
Published in:
British journal of clinical pharmacology (2020)
Keyphrases
</>
dendritic cells
bone marrow
acute myeloid leukemia
chronic myeloid leukemia
immune response